Format

Send to

Choose Destination
Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S233-5. doi: 10.4103/2230-8210.104047.

Low density Lipoprotein cholesterol target: Changing goal posts.

Author information

1
Department of Endocrinology, St. Johns Medical College Hospital, Bangalore - 560 034, Karnataka, India.

Abstract

Elevated low density lipoprotein cholesterol (LDL) has been identified as one of the strongest correctable risk factors for cardiovascular disease in patients with diabetes. The reduction in cardiovascular events with pharmacological therapy aimed at LDL lowering is well documented in both primary prevention and secondary prevention. In this article, we review the evolving trend of aggressive LDL cholesterol lowering strategies.

KEYWORDS:

LDL; cardiovascular disease; diabetes

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center